Research Progress on the Role of IL-7 Protein in Adaptive Immune Dysregulation during Sepsis

1. Sepsis-Induced Immunosuppression and Adaptive Immune Dysregulation

Sepsis is one of the leading causes of death in intensive care units, with its core mechanism lying in immune dysfunction. Recent clinical studies show that lymphopenia occurs early in sepsis, affecting T cells, B cells, and dendritic cells. Autopsies reveal that the depletion of CD4+ and CD8+ T cells in septic patients' spleens, lymph nodes, and circulation far exceeds inflammatory cell infiltration, indicating that immune paralysis due to adaptive immune cell exhaustion is a hallmark of sepsis pathophysiology. T-cell anergy—marked by apoptosis, reduced counts, and abnormal differentiation—has long been recognized as a key feature of sepsis-related immune dysfunction.

2. The Role of Regulatory T Cells in Sepsis

Regulatory T cells (Tregs) are a subset of mature T cells with immunosuppressive functions, modulating excessive immune responses by inhibiting effector cell proliferation and activity. CD4+CD25+ Tregs, the most studied natural Tregs, express CD25 and primarily mediate immune suppression and tolerance. During early sepsis, cytokine storms trigger systemic inflammatory response syndrome (SIRS). To counterbalance this hyperinflammation, Foxp3+ Tregs enhance immunosuppression, which becomes dominant in later stages. Studies show elevated Foxp3 mRNA expression in septic patients. While innate and adaptive immune cells undergo significant apoptosis in sepsis, Tregs remain relatively resistant, leading to their proportional increase. This further suppresses CD4+ and CD8+ T-cell activation and proliferation, exacerbating immune paralysis and mortality risk.

3. Molecular Features of IL-7 Protein and Its Receptor

IL-7 is a pleiotropic glycoprotein (~25 kDa) primarily secreted by thymic and bone marrow stromal cells, though dendritic cells, keratinocytes, megakaryocytes, and lymphatic endothelial cells also produce it. It exerts biological effects by binding to high-affinity cell surface receptors. The IL-7 receptor consists of an α-chain (IL-7Rα, unique to IL-7) and a γ-chain (shared by multiple cytokines). IL-7 activates Janus kinase (JAK) signaling via CD127 and CD132 receptor complexes, promoting STAT5 and PI3K pathways, upregulating anti-apoptotic proteins, and enhancing T-cell development, differentiation, and survival. IL-7 receptors are abundantly expressed on T cells and hematopoietic progenitors.

4. Biological Functions of IL-7 Protein

IL-7 plays a pivotal role in T-cell development, proliferation, and homeostasis. Post-thymic T cells rely on IL-7 for survival via anti-apoptotic and co-stimulatory signals. It is essential for thymocyte maturation, lymphoid cell homeostasis, and the expansion of CD4+/CD8+ T cells and memory T cells. Additionally, IL-7 supports dendritic cell development and monocyte activation, inducing cytokine secretion. By upregulating Bcl-2 family proteins, IL-7 mitigates sepsis-induced immune cell apoptosis.

5. IL-7's Immunomodulatory Effects

IL-7 is critical for maintaining CD4+/CD8+ T-cell homeostasis. In healthy individuals, serum IL-7 levels inversely correlate with IL-7Rα expression and T-cell counts. Septic patients exhibit elevated Tregs, where CD127 (IL-7Rα) serves as a marker. Low CD127 correlates with high Foxp3 expression. Sepsis disrupts IL-7/IL-7R balance: lymphopenia reduces IL-7 production, while IL-7R downregulation further impairs IL-7 signaling.

6. Suppliers of IL-7 Protein

Nanjing UA-BioTech Co., Ltd. (UA-Bio) offers "IL-7 Protein, Human", a premium recombinant protein for lymphocyte research. This human IL-7 variant activates IL-7R signaling, promoting B-cell, T-cell, and innate lymphoid cell (ILC) development—ideal for hematopoietic studies, immunodeficiency models, and CAR-T therapy.

UA-Bio specializes in cutting-edge reagents for immunology and cell therapy. For details on "IL-7 Protein, Human" (Cat# UA040118), contact us today.